Skip to main content

Table 1 The clinical features of the two groups

From: Inflammation is correlated with severity and outcome of cerebral venous thrombosis

  CVT patients
n = 95
Control individuals
n = 41
P value
Age, years 38.93 ± 13.53 40.90 ± 16.70 0.469
Gender (female, %) 60 63.41 0.708
Hs-CRP 3.3 (0.7, 11.73) 0.5 (0.26, 1.6) < 0.001
IL-6 9.49 (5.76, 14.94) 4.32 (3.01, 5.02) 0.003
NLR 2.84 (1.86, 3.73) 2.05 (1.77, 2.59) < 0.001
CSF IgA 0.4 (0.24, 0.81) 0.2 (0.13, 0.23) < 0.001
CSF IgM 1.3 (0.5, 2.6) 0.04 (0.02, 0.08) < 0.001
CSF IgG 3.48 (2.22, 5.56) 2.54 (1.98, 2.88) 0.001
  1. CVT cerebral venous thrombosis, Hs-CRP hypersensitive C-reactive protein, Il-6 interleukin-6, NLR the neutrophil to lymphocyte ratio, IgA immunoglobulin A, IgM immunoglobulin M, IgG immunoglobulin G, CSF cerebrospinal fluid